Inventor · disambiguated record
Wing-Kee Philip Cho
Also filed as: CHO WING-KEE P · CHO WING-KEE PHILIP
11 granted patents·9 pending applications·385 citations·filing 1989–2014
91Inventor score
Top patents by PatentIndex Score
20 records- 0195US5100675ASustained release tablet comprising loratadine, ibuprofen and pseudoephedrineSCHERING CORP·Filed 1990·Granted Mar 31, 1992·154 cites·10 claims
- 0293US6709676B2Extended release oral dosage compositionSCHERING CORP·Filed 2002·Granted Mar 23, 2004·59 cites·41 claims
- 0393US4990535APharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrineSCHERING CORP·Filed 1989·Granted Feb 5, 1991·128 cites·12 claims
- 0484US8361500B2Tablet formulations containing 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefromOPKO HEALTH INC·Filed 2008·Granted Jan 29, 2013·8 cites·9 claims
- 0584US7772178B2Pharmaceutical formulations and methods of treatment using the sameSCHERING CORP·Filed 2006·Granted Aug 10, 2010·17 cites·10 claims
- 0682US7030106B2Sterol absorption inhibitor compositionsSCHERING CORP·Filed 2002·Granted Apr 18, 2006·12 cites·2 claims
- 0773US7618649B2Extended release oral dosage compositionSCHERING CORP·Filed 2003·Granted Nov 17, 2009·5 cites·18 claims
- 0868US8187630B2Extended release oral dosage compositionCHO WING-KEE PHILIP·Filed 2009·Granted May 29, 2012·1 cites·29 claims
- 0968US7718643B2Pharmaceutical formulationSCHERING CORP·Filed 2009·Granted May 18, 2010·0 cites·3 claims
- 1064US7612058B2Methods for inhibiting sterol absorptionSCHERING CORP·Filed 2004·Granted Nov 3, 2009·1 cites·10 claims
- 1157US2008275020A1Pharmaceutical formulationSCHERING CORP·Filed 2008·Application pending·0 cites
- 1256US2015283121A1Tablet formulations containing 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefromOPKO HEALTH INC·Filed 2014·Application pending·0 cites
- 1354US8420122B2Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing sameZARKADAS DIMITRIOS·Filed 2008·Granted Apr 16, 2013·0 cites·4 claims
- 1454US2007237818A1Controlled-release formulation of HCV protease inhibitor and methods using the sameMALCOLM BRUCE A·Filed 2006·Application pending·0 cites
- 1554US2007160666A1Pharmaceutical formulationSCHERING CORP·Filed 2007·Application pending·0 cites
- 1652US2013122088A1Tablet formulations containing 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefromOPKO HEALTH INC·Filed 2013·Application pending·0 cites
- 1750US2006275366A1Controlled-release formulationSCHERING CORP·Filed 2006·Application pending·0 cites
- 1850US2006199793A1Sterol absorption inhibitor compoundsCHO WING-KEE P·Filed 2005·Application pending·0 cites
- 1938US2008193518A1Process for the precipitation and isolation of 6,6-Dimethyl-3-Aza Bicyclo [3.1.0] Hexane-Amide compounds by controlled precipitation and pharmaceutical formulations containing sameSCHERING CORP·Filed 2007·Application pending·0 cites
- 2034US2012294935A1Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing sameZARKADAS DIMITRIOS·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →